- Home
- / InhaleRx
InhaleRx
Stock Price
$0
2024-10-28
Market Capitalization
$6.3 M
2024-10-28
InhaleRx Summary
Company Summary
- Overview
- InhaleRx (formerly known as Lifespot Health) is a company that provides inhaled medication systems. It offers the Medihale, a sealed pod inhaler for inhaled cannabinoid-based formulations use to treat panic disorders and complex regional pain syndrome (CRPS).
- Type
- Public
- Status
- Active
- Founded
- 2016
- HQ
- Melbourne, AU | view all locations
- Website
- https://inhalerx.com.au/
- Cybersecurity rating
Table of Contents
Key People
Greg Plunkett, Non-Executive Director
Frank Canavo, Non-Executive Director
LocationsView all
1 location detected
Melbourne, VIC HQ
Australia
820 suite 103 level/1 Queen St
InhaleRx Financials
Summary Financials
- Gross profit (FY, 2025)
- $986.0K
- Net income (FY, 2025)
- ($1.6M)
- Cash (FY, 2025)
- $437.0K
- EBIT (FY, 2025)
- ($1.5M)
- Enterprise value
- $6.6M